~~<i id='E827748387'><strike id='E827748387'><tt id='E827748387'><pre id='E827748387'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：knowledge 2025-09-06 01:57:37 - browse：964

A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

However, some outside experts expressed skepticism about the result.

Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin — is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Questions and answers about ramping up H5N1 bird flu vaccine

explore

leisure time

explore

focus

knowledge

MicroscopicimageofH5N1avianinfluenzavirusparticles(inorange).CDCandNIAIDAsecondhumancaseofH5N1birdfl

WSS

Questions and answers about ramping up H5N1 bird flu vaccine

Eli Lilly’s Zepbound improved liver scarring in mid

For longer

Listen: More tumult at BIO & coercive care for sickle cell patients

CMS got Medicare Advantage quality rating wrong, judge rules

FTC loses bid to block Novant's North Carolina hospital merger

entertainment

leisure time

explore

Virginia high school admissions case could be legal follow

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

The cancer drug shortage isn’t new — and neither are the solutions

Stopping antidepressants leads to symptoms for 1 in 6 patients

United colonoscopy coverage change 'may cost lives,' doctors say

Making the case for fair compensation in clinical trials

Tori Bowie and the unacceptable rates of Black maternal death

ASCO eve: Let’s set the table for this year's meeting

Duchenne breakthrough therapy leaves behind pioneering families

BD to buy Edwards patient monitoring unit for $4.2 billion

leisure time

Listen: More tumult at BIO & coercive care for sickle cell patients

Elevance PBM president out as customers face prescription chaos

CMS got Medicare Advantage quality rating wrong, judge rules

Reports of telehealth's death have been greatly exaggerated

Investigation reveals sickle cell patients pressured into sterilizations

Fentanyl is making it harder to start addiction treatment

explore

focus

focus

knowledge